Get started
Author

Michaël Hummelsberger

Observed names: M Hummelsberger, M. Hummelsberger, M.J. Hummelsberger, Michael HUMMELSBERGER, Michael Hummelsberger
ORCID: 0009-0003-0513-6572
Observed ORCID: 0009-0003-0513-6572
OpenAlex ID: A5066197793
Preclinical targeting of NF-κB and FLT3 pathways in AML cells
2008 · E Griessinger, C Frelin, et al. · Leukemia · 36
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
2023 · Véronique VENDRELY, Claire LEMANSKI, et al. · Radiotherapy and Oncology · 22
PDF
Granocyte-colony stimulating factor (G-CSF) has significant efficacy as secondary prophylaxis of chemotherapy-induced neutropenia in patients with solid tumors: results of a prospective study.
2013 · Gilles Freyer, Nicolas Jovenin, et al. · PubMed · 10
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE
2024 · Claire Gouriou, Claire Lemanski, et al. · British Journal of Cancer · 5
PDF
Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature
2023 · Angèle Lallement, Anouck Lamoureux, et al. · Clinics and Research in Hepatology and Gastroenterology · 3
PDF
Interpretable AI to predict anal cancer local failure at 3 years with the FFCD Anabase prospective multicentric cohort
2026 · C. Raynaud, V. Vendrely, et al. · Radiotherapy and Oncology
178P Interpretable AI to predict anal cancer local failure at 3 years with the FFCD Anabase prospective multicentric cohort
2025 · C. Raynaud, V. Vendrely, et al. · ESMO Real World Data and Digital Oncology
PDF
429P Management of localized anal cancer and prognostic factors in the elderly: Results of the French multicenter cohort FFCD – ANABASE
2022 · C. Gouriou, C. Lemanski, et al. · Annals of Oncology
OC-0270 Final results of the French national cohort ANABASE : treatment and outcome in anal cancer
2022 · V. Vendrely, C. Lemanski, et al. · Radiotherapy and Oncology
Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.
2006 · Anne Sirvent, Michael Hummelsberger, et al. · Blood
Pharmacological Blockade of NF-kB with AS602868, a Potent Small Molecule Inhibitor of IKK2 Leads to Apoptosis of Sensitive and Resistant Chronic Myeloid Leukemia Cells.
2005 · Veronique Imbert, Nadege Gonthier, et al. · Blood
Érythermalgie régressive : évolution inhabituelle au cours d’une infection par le VIH
2004 · Stéphanie Roth, Nathalie Tieulié, et al. · La Presse Médicale
Works count: 12
Citation count: 76
H-index: 4
I10-index: 3
Year
Topic
Type